Figure 1.
Power comparison of the TRF-pathway with PLINK and RF-pathway at the 0.05 and 0.01 significance levels.
Table 1.
Type I error rates for the TRF-pathway, RF-pathway, and PLINK set-based tests.
Table 2.
Pathway analysis results for the breast cancer GWAS data.
Table 3.
Pathway analysis results for the lung cancer GWAS data.